SOURCE: Equity News Circuit

Equity News Circuit

January 30, 2013 08:45 ET

Free Research Reports on KLIC, OXF, SWIR and VTUS Issued by the Bedford Report

Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT

NEW YORK, NY--(Marketwire - Jan 30, 2013) - The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

Kulicke and Soffa Industries Inc. (NASDAQ: KLIC) declined nearly 9 percent on more than five-times the average daily volume Tuesday. The company expects net revenue in the second fiscal quarter of 2013 to be approximately $90 million to $100 million, compared to $114 million reported for the fiscal first quarter.

Find out more about Kulicke and Soffa Industries including full access to the free equity report at: www.BedfordReport.com/KLIC

Oxford Resource Partners, LP (NYSE: OXF) shares plummeted 31 percent on more than ten-times the average daily volume Tuesday. The coal miner has decided to suspend their cash distributions for the fourth quarter due to "continued weakness in the coal markets".

Find out more about Oxford Resource Partners including full access to the free equity report at: www.BedfordReport.com/OXF

Sierra Wireless, Inc. (NASDAQ: SWIR) shares soared 16.5 percent on over 1 million shares traded Tuesday, which was more than 20 time the average daily volume. The company has recently agreed to sell assets and operations related to its AirCard business to NETGEAR, Inc.

Find out more about Sierra Wireless including full access to the free equity report at: www.BedfordReport.com/SWIR

Ventrus Biosciences Inc. (NASDAQ: VTUS) is a specialty pharmaceutical company focused on the late-stage clinical development of gastrointestinal products in areas of unmet need, anal fissures, and fecal incontinence. Shares of the company surged over 17 percent on a large volume spike which was eight-times the average daily volume Tuesday.

Find out more about Ventrus Biosciences including full access to the free equity report at: www.BedfordReport.com/VTUS

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein.

A third party, Providence Media Strategies LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information